Irish-founded hVIVO lands €7.5m contract to test vaccines

The trials are aimed at eliminating respiratory diseases which kill thousands of people each year

Cathal Friel, the chairman of hVIVO, which was formerly named Open Orphan. Picture: Fergal Phillips

hVIVO, an Irish-founded research organisation, has signed a major contract worth £6.8 million (€7.6 million) to test vaccines.

The company, formerly known as Open Orpahn, said the deal was with a “leading pharmaceutical company based in Asia Pacific”, however it did not name the business.

The contract is for hVIVO to test the company’s respiratory syncytial virus (RSV) antiviral drug candidate. The research will be carried out on healthy volunteers at hVIVO's specialist facilities in ...